Can peptide receptor radionuclide therapy be safely applied in florid bone metastases of gastroenteropancreatic neuroendocrine tumours?

被引：0
作者：
Sabet, Amir [1 ]
Yong-Hing, Charlotte [2 ]
Ezziddin, Khaled [1 ]
Ahmadzadehfar, Hojjat [1 ]
Guhlke, Stefan [1 ]
Gruenwald, Frank [3 ]
Biersack, Hans Juergen [1 ]
Ezziddin, Samer [1 ]
机构：
[1] Dept Nucl Med, Bonn, Germany
[2] Univ British Columbia, Vancouver, BC, Canada
[3] Univ Hosp, Frankfurt, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1183
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The role of peptide receptor radionuclide therapy in patients with lung neuroendocrine tumours
    Filice, Angelina
    Fraternali, Alessandro
    Fioroni, Federica
    Froio, Armando
    Di Paolo, Maria Liberata
    Casali, Massimiliano
    Roncali, Massimo
    Grassi, Elisa
    Asti, Mattia
    Versari, Annibale
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] Peptide receptor radionuclide therapy as neoadjuvant treatment in pancreatic neuroendocrine tumours
    Prospero, I.
    Ferreira, G.
    Ferro, J. C.
    Barbosa, D.
    Silva, D. G.
    Fontao de Castro, S.
    Teixeira, J. P.
    Duarte, H.
    Lucena Sampaio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S220 - S220
  • [23] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Michael S. Hofman
    Rodney J. Hicks
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 211 - 213
  • [24] Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?
    Hofman, Michael S.
    Hicks, Rodney J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (02) : 211 - 213
  • [25] Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours
    Adant, Samuel
    Shah, Girish M.
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (04) : 907 - 921
  • [26] Peptide receptor radionuclide therapy for advanced gastroenteropancreatic neuroendocrine tumors - from oncology perspective
    Kolasinska-Cwikla, Agnieszka
    Lowczak, Anna
    Maciejkiewicz, Katarzyna
    Cwikla, Jaroslaw B.
    NUCLEAR MEDICINE REVIEW, 2018, 21 (02) : 115 - 124
  • [27] Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors
    Tobias, Joseph
    Abou Azar, Sara
    Gujarathi, Rushabh
    Nordgren, Rachel
    Vaghaiwalla, Tanaz
    Millis, J. Michael
    Feinberg, Nicholas
    Liao, Chih-Yi
    Keutgen, Xavier M.
    SURGERY, 2025, 177
  • [28] Quality Of Life in Patients with Neuroendocrine Gastroenteropancreatic Tumors Treated with Peptide Receptor Radionuclide Therapy
    Georgakopoulos, A.
    Liotsou, T.
    Chatziioannou, S. N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S691 - S691
  • [29] Efficacy of Peptide Receptor Radionuclide Therapy in Patients with Advanced Bronchial Neuroendocrine Tumours
    Koffas, A.
    Popat, R.
    Mohmaduvesh, M.
    Quigley, A. M.
    Navalkissoor, S.
    Caplin, M.
    Toumpanakis, C.
    NEUROENDOCRINOLOGY, 2016, 103 : 81 - 81
  • [30] Peptide receptor radionuclide therapy in non-neuroendocrine tumours - a field report
    Nilica, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S223 - S223
12345